Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

Factors related to self-rated health and life satisfaction one year after radical prostatectomy for localised prostate cancer: a cross-sectional survey.

Talvitie AM, Ojala H, Tammela T, Koivisto AM, Pietilä I.

Scand J Caring Sci. 2019 Mar 13. doi: 10.1111/scs.12664. [Epub ahead of print]

PMID:
30866074
3.

Androgen receptor enhancer usage and the chromatin regulatory landscape in human prostate cancers.

Stelloo S, Bergman AM, Zwart W.

Endocr Relat Cancer. 2019 Mar 1. pii: ERC-19-0032.R1. doi: 10.1530/ERC-19-0032. [Epub ahead of print] Review.

PMID:
30865928
4.

Re: Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance Imaging.

Taneja SS.

J Urol. 2019 Mar 13:101097JU0000000000000231. doi: 10.1097/JU.0000000000000231. [Epub ahead of print] No abstract available.

PMID:
30865852
5.

Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study.

Armstrong AJ, Halabi S, Luo J, Nanus DM, Giannakakou P, Szmulewitz RZ, Danila DC, Healy P, Anand M, Rothwell CJ, Rasmussen J, Thornburg B, Berry WR, Wilder RS, Lu C, Chen Y, Silberstein JL, Kemeny G, Galletti G, Somarelli JA, Gupta S, Gregory SG, Scher HI, Dittamore R, Tagawa ST, Antonarakis ES, George DJ.

J Clin Oncol. 2019 Mar 13:JCO1801731. doi: 10.1200/JCO.18.01731. [Epub ahead of print]

PMID:
30865549
6.

Moving Beyond Gleason Scoring.

Miles B, Ittmann M, Wheeler T, Sayeeduddin M, Cubilla A, Rowley D, Bu P, Ding Y, Gao Y, Lee M, Ayala GE.

Arch Pathol Lab Med. 2019 Mar 13. doi: 10.5858/arpa.2018-0242-RA. [Epub ahead of print]

PMID:
30865488
7.

Essential Updates in Grading, Morphotyping, Reporting, and Staging of Prostate Carcinoma for General Surgical Pathologists.

Paner GP, Gandhi J, Choy B, Amin MB.

Arch Pathol Lab Med. 2019 Mar 13. doi: 10.5858/arpa.2018-0334-RA. [Epub ahead of print]

PMID:
30865487
8.

Clinical determinants for successful circulating tumor DNA analysis in prostate cancer.

Schweizer MT, Gulati R, Beightol M, Konnick EQ, Cheng HH, Klemfuss N, De Sarkar N, Yu EY, Montgomery RB, Nelson PS, Pritchard CC.

Prostate. 2019 Mar 13. doi: 10.1002/pros.23778. [Epub ahead of print]

PMID:
30865311
9.

Contemporary treatments in prostate cancer focal therapy.

Ahdoot M, Lebastchi AH, Turkbey B, Wood B, Pinto PA.

Curr Opin Oncol. 2019 Mar 8. doi: 10.1097/CCO.0000000000000515. [Epub ahead of print]

PMID:
30865133
10.

Multi-Institutional Outcomes of Minimally Invasive Harvest of Rectal Mucosa Graft for Anterior Urethral Reconstruction.

Granieri MA, Zhao LC, Breyer BN, Voelzke BB, Baradaran N, Grucela AL, Marcello P, Vanni AJ.

J Urol. 2019 Jan 29:101097JU0000000000000087. doi: 10.1097/JU.0000000000000087. [Epub ahead of print]

PMID:
30864909
11.

Linac-based stereotactic body radiation therapy vs moderate hypofractionated radiotherapy in prostate cancer: propensity-score based comparison of outcome and toxicity.

Franzese C, D'agostino G, Di Brina L, Navarria P, De Rose F, Comito T, Franceschini D, Mancosu P, Tomatis S, Scorsetti M.

Br J Radiol. 2019 Mar 13:20190021. doi: 10.1259/bjr.20190021. [Epub ahead of print]

PMID:
30864833
12.

SERS based Pump-free Microfluidic Chip for Highly Sensitive Immunoassay of Prostate-specific Antigen Biomarkers.

Gao R, Lv Z, Mao Y, Yu L, Bi X, Xu S, Cui J, Wu YC.

ACS Sens. 2019 Mar 13. doi: 10.1021/acssensors.9b00039. [Epub ahead of print]

PMID:
30864786
13.

Combination of phospholipase Cε knockdown with GANT61 sensitizes castration‑resistant prostate cancer cells to enzalutamide by suppressing the androgen receptor signaling pathway.

Sun W, Li L, Du Z, Quan Z, Yuan M, Cheng H, Gao Y, Luo C, Wu X.

Oncol Rep. 2019 Mar 7. doi: 10.3892/or.2019.7054. [Epub ahead of print]

PMID:
30864728
14.

Estrogen receptor β suppresses inflammation and the progression of prostate cancer.

Xiao L, Luo Y, Tai R, Zhang N.

Mol Med Rep. 2019 Mar 6. doi: 10.3892/mmr.2019.10014. [Epub ahead of print]

PMID:
30864712
15.

Effect of docetaxel on the regulation of proliferation and apoptosis of human prostate cancer cells.

Yang C, Zhang W, Wang J, Chen P, Jin J.

Mol Med Rep. 2019 Mar 1. doi: 10.3892/mmr.2019.9998. [Epub ahead of print]

PMID:
30864701
16.

URG11 promotes proliferation and induced apoptosis of LNCaP cells.

Sun C, Zhang G, Cheng S, Qian H, Li D, Liu M.

Int J Mol Med. 2019 Mar 5. doi: 10.3892/ijmm.2019.4121. [Epub ahead of print]

PMID:
30864678
17.

Sodium-glucose cotransporters: new targets of cancer therapy?

Madunić IV, Madunić J, Breljak D, Karaica D, Sabolić I.

Arh Hig Rada Toksikol. 2018 Dec 1;69(4):278-285. doi: 10.2478/aiht-2018-69-3204.

PMID:
30864374
18.

Fatigue and physical activity in cancer survivors: A cross-sectional population-based study.

Matias M, Baciarello G, Neji M, Di Meglio A, Michiels S, Partridge AH, Bendiane MK, Fizazi K, Ducreux M, Andre F, Vaz-Luis I.

Cancer Med. 2019 Mar 12. doi: 10.1002/cam4.2060. [Epub ahead of print]

19.

On the feasibility of transperineal 3D ultrasound image guidance for robotic radical prostatectomy.

Mathur P, Samei G, Tsang K, Lobo J, Salcudean S.

Int J Comput Assist Radiol Surg. 2019 Mar 13. doi: 10.1007/s11548-019-01938-w. [Epub ahead of print]

PMID:
30863982
20.

Association of single nucleotide polymorphism in hsa-miR-499 and hsa-miR-196a2 with the risk of prostate cancer.

Nouri R, Ghorbian S.

Int Urol Nephrol. 2019 Mar 13. doi: 10.1007/s11255-019-02099-0. [Epub ahead of print]

PMID:
30863967

Supplemental Content

Loading ...
Support Center